Detalles de la búsqueda
1.
The glycosylated extracellular domain of MUC1 protects against SARS-CoV-2 infection at the respiratory surface
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-466408
2.
A human monoclonal antibody targeting a conserved pocket in the SARS-CoV-2 receptor-binding domain core
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-318261
3.
Qualitative Changes in the SARS-CoV-2 Antibody Response in the Post-Infection Phase Impact the estimates of infections in Population-Based Seroprevalence Studies
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20153536
4.
Structural basis for broad coronavirus neutralization
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-424482
5.
A human monoclonal 1 antibody blocking SARS-CoV-2 infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-987958
6.
Elevated mucosal antibody responses against SARS-CoV-2 are correlated with lower viral load and faster decrease in systemic COVID-19 symptoms
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21250910
7.
Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20249035
8.
Homologous and heterologous antibodies to coronavirus 229E, NL63, OC43, HKU1, SARS, MERS and SARS-CoV-2 antigens in an age stratified cross-sectional serosurvey in a large tertiary hospital in The Netherlands
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20177857
9.
SARS-CoV-2 specific antibody responses in COVID-19 patients
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20038059
10.
A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-516114
11.
An alphavirus replicon-based vaccine expressing a stabilized Spike antigen induces sterile immunity and prevents transmission of SARS-CoV-2 between cats
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-436305
12.
RAPPID: a platform of ratiometric bioluminescent sensors for homogeneous immunoassays
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-363044
13.
Isolation of cross-reactive monoclonal antibodies against divergent human coronaviruses that delineate a conserved and vulnerable site on the spike protein
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-346916
14.
SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-264630
15.
Coronavirus hemagglutinin-esterase and spike proteins co-evolve for functional balance and optimal virion avidity
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-003699
16.
Development of a SARS-CoV-2 total antibody assay and the dynamics of antibody response over time in hospitalized and non-hospitalized patients with COVID-19
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20133793
17.
An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-480751
18.
Multi-specific DARPin(R) therapeutics demonstrate very high potency against mutated SARS-CoV-2 variants in vitro
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-429164
19.
Highly potent anti-SARS-CoV-2 multi-DARPin therapeutic candidates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-256339
Resultados
1 -
19
de 19
1
Próxima >
>>